Tuesday, May 20, 2025 | 10:08 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

World Coronavirus Dispatch: J&J announces final stage trials of vaccine

French biz confidence up despite resurgence, China eases entry rules for some foreigners, tough times for airlines as attempts to reopen falter, and other pandemic-related news across the globe

Coronavirus
Premium

FILE PIC: A healthcare worker in PPE holds a vial after collecting a swab sample from a person at a local health center to conduct tests for the coronavirus disease (COVID-19)

Yuvraj Malik New Delhi
The feverish race for a coronavirus vaccine got an infusion of energy on Wednesday as Johnson & Johnson announced that it has begun the final stage of its clinical trials, the fourth company to do so in the United States, which has passed a grim milestone of 200,000 deaths from the pandemic.

Johnson & Johnson is a couple of months behind the leaders, but its vaccine trial will be by far the largest, enrolling 60,000 participants. The company said it could know by the end of this year if its vaccine works. Read more here
 
Let’s look at the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in